 |
|
Is late diagnosis of lung cancer inevitable?
March 23, 2005A study by researchers into the diagnosis of patients with lung cancer suggests that avoidable patient delays in reporting symptoms of the disease is an important factor in its treatment.
The research carried out by the University of Southampton indicates that the widely held view that lung cancer is silent until far advanced may be inaccurate.
Lung cancer remains the most common cause of death from cancer in the UK with over 33,000 deaths a year. Delay in the diagnosis of cancer is recognised as an important factor in the overall outcome of treatment. Currently, little is known about the pathway to diagnosis for cancer, especially lung cancer. However there is evidence to suggest that avoidable delays in diagnosis occur and that these are attributable to both doctor and patient behaviour.
In this new study, researchers interviewed 22 patients recently diagnosed with lung cancer at two cancer centres in the north and south of England. The interviews were used to map the history of their symptoms leading up to the diagnosis. Patients were asked to describe the nature and number of symptoms they recalled before diagnosis and to pinpoint when the health changes that ultimately led to the diagnosis of lung cancer started. Recollections more than two years before the diagnosis were not recorded as they were deemed to be insufficiently detailed. The accounts were compared with hospital and primary care records to check patients' recall.
All the patients recalled having new symptoms for many months prior to their diagnosis. A total of 30 different symptoms were experienced by patients before diagnosis, ranging from chest symptoms such as cough and breathing changes to fatigue, lethargy or weight loss which is considered to be a symptom of the advanced disease.
Although these symptoms were reported as being marked changes in their health, patients did not interpret these changes as serious or as symptoms of lung cancer and did not see their GP to discuss them. Instead they frequently sought to manage the problem themselves until it became too difficult.
Despite the fact that all but one of the patients were current or former smokers, it appeared that symptoms such as breathing changes or profound fatigue were not associated with the possibility that these might be symptoms of lung cancer. Instead, symptoms were attributed to everyday causes such as getting lder.
Professor Jessica Corner, Professor of Palliative Care at the University of Southampton and Director for Improving Cancer Services, Macmillan Cancer
Relief, comments: 'These results indicate that developing greater understanding of how people respond to changes in their health - especially when these are a prelude to a disease that holds very negative commutations such as lung cancer - could be used to inform the development of strategies to promote earlier diagnosis.
'There is a clear need for different approaches to public health whereby people at risk are encouraged to be more conscious of their health and to the possibility that they may develop lung cancer. If successful, this may lead to earlier presentation, faster diagnosis and better outcomes.'
Southampton, University of
In this new study, researchers interviewed 22 patients recently diagnosed with lung cancer at two cancer centres in the north and south of England. The interviews were used to map the history of their symptoms leading up to the diagnosis. Patients were asked to describe the nature and number of symptoms they recalled before diagnosis and to pinpoint when the health changes that ultimately led to the diagnosis of lung cancer started. Recollections more than two years before the diagnosis were not recorded as they were deemed to be insufficiently detailed. The accounts were compared with hospital and primary care records to check patients' recall.
All the patients recalled having new symptoms for many months prior to their diagnosis. A total of 30 different symptoms were experienced by patients before diagnosis, ranging from chest symptoms such as cough and breathing changes to fatigue, lethargy or weight loss which is considered to be a symptom of the advanced disease.
Although these symptoms were reported as being marked changes in their health, patients did not interpret these changes as serious or as symptoms of lung cancer and did not see their GP to discuss them. Instead they frequently sought to manage the problem themselves until it became too difficult.
Despite the fact that all but one of the patients were current or former smokers, it appeared that symptoms such as breathing changes or profound fatigue were not associated with the possibility that these might be symptoms of lung cancer. Instead, symptoms were attributed to everyday causes such as getting lder.
Professor Jessica Corner, Professor of Palliative Care at the University of Southampton and Director for Improving Cancer Services, Macmillan Cancer
Relief, comments: 'These results indicate that developing greater understanding of how people respond to changes in their health - especially when these are a prelude to a disease that holds very negative commutations such as lung cancer - could be used to inform the development of strategies to promote earlier diagnosis.
'There is a clear need for different approaches to public health whereby people at risk are encouraged to be more conscious of their health and to the possibility that they may develop lung cancer. If successful, this may lead to earlier presentation, faster diagnosis and better outcomes.'
Southampton, University of
Lung Cancer Current Events and Lung Cancer News RSSCommon pain relief medication may encourage cancer growth
Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of cancer cells.
Study raises concerns about outdoor second-hand smoke
Indoor smoking bans have forced smokers at bars and restaurants onto outdoor patios, but a new University of Georgia study in collaboration with the Centers for Disease Control and Prevention suggests that these outdoor smoking areas might be creating a new health hazard.
Carnegie Mellon researchers link health-care debate to risk of dying in US and Europe
The current health care debate in the United States is complicated. Trade-offs between heath care expenditures, lifestyle choices and life expectancy have been suggested but seldom clearly demonstrated.
PET imaging response a prognostic factor after thoracic radiation therapy for lung cancer
A rapid decline in metabolic activity on a PET scan after radiation therapy for non-small cell lung cancer is correlated with good local tumor control, according to a study presented by researchers at Thomas Jefferson University Hospital at the 51st ASTRO Annual Meeting.
Study of concurrent radiotherapy, chemotherapy shows promise in small cell lung cancer
Treating limited stage small cell lung cancer(LSCL) with a combination of accelerated high-dose radiotherapy and chemotherapy has shown encouraging results.
Stereotactic radiotherapy offers noninvasive, effective treatment for frail patients with early-stage lung cancer
Stereotactic body radiation therapy (SBRT) should be considered a new standard of care for early-stage lung cancer treatment in patients with co-existing medical problems, according to results from a national clinical trial led by UT Southwestern Medical Center physicians.
Preventative brain radiation for lung cancer patients: Benefits and risks
A new study is taking a closer look at the benefits versus risks for lung cancer patients to undergo preventative brain radiation therapy as a means to stop cancer from spreading to the brain.
Study spotlights efficacy of questionnaire to identify patients at high risk for lung cancer
A study featured in the November issue of the Journal of Thoracic Oncology confirms the success of a simple questionnaire designed to identify patients at high risk of lung cancer.
Intervals between lung cancer diagnosis and treatment displays a health care disparity
Research published in the November 2009 issue of the Journal of Thoracic Oncology has found that intervals between lung cancer suspicion, diagnosis and treatment may be attributed to health care system discrepancies.
Researchers use drug-radiation combo to eradicate lung cancer
Researchers at UT Southwestern Medical Center have eliminated non-small cell lung (NSCL) cancer in mice by using an investigative drug called BEZ235 in combination with low-dose radiation.
More Lung Cancer Current Events and Lung Cancer News Articles
 |
How to Survive Lung Cancer - A Practical 12-Step Plan by Michael Lloyd (Author) Written by a lung cancer survivor who understands what it takes to beat the odds, this book offers unparalleled hope and direction for anyone facing this illness. It is filled with specific exercises and techniques to promote healing and reverse side effects by taking a pro-active approach in helping to restore your mind, body and spirit to an optimum state of health. Endorsed by a Lung Cancer Specialist and Associate Professor at Harvard Medical School, this book combines what the doctors tell you with critical information they don't tell you. Visit www.SurviveLungCancer.com for chapter summaries. |
 |
Lung Cancer: Myths, Facts, Choices--and Hope by Claudia I. Henschke (Author), Peggy McCarthy (Author), Sarah Wernick (Contributor) Winner of the 2003 American Society of Journalists and Authors' June Roth Memorial Award for Health and Medical Books. An authoritative book with new lifesaving strategies for those at risk and those already diagnosed. Lung cancer kills more women than breast cancer, more men than prostate cancer—because it's usually found too late. Claudia Henschke's groundbreaking research on early diagnosis, published in The Lancet, made headlines worldwide. Now, for the first time, she offers specific recommendations based on her latest findings: who needs to be checked, where to be tested, and what to expect. Dr. Henschke and coauthor Peggy McCarthy, a leading patient advocate, provide up-to-the-minute information on diagnosis, treatment, and survival, accompanied by inspiring words from... |
 |
Voices of Lung Cancer: The Healing Companion: Stories for Courage, Comfort and Strength (Voices Of series) by The Healing Project (Editor), S. Epatha Merkerson (Editor) Provided by the patients, their friends, families, and caregivers of those diagnaosed with lung cancer, these very personal stories offer inspired insight into the ways families and professionals care for both themselves and the patient, gain a deeper understanding of the relationships, and learn to come to terms with the end of life. Included are essays by medical experts about the science of lung cancer, current treatments, choosing the right doctors, and what the future holds for the next generation of patients. |
 |
Quick Facts on Lung Cancer by American Cancer Society (Author) Educate yourself about lung cancer What are your risk factors for lung cancer? Can you prevent it? How is lung cancer treated? What should you ask your doctor? QuickFACTS Lung Cancer is both a comprehensive and a quick read, with highlighted cover tabs for quick reference of specific topics. QuickFACTS Lung Cancer: Covers everything from risk factors to living well after cancer treatment Provides critical questions to ask your healthcare team Educates and empowers you right from the start Completely updated with the latest patient treatment guidelines Includes a lung cancer dictionary |
 |
Lung Cancer by Jack A. Roth (Author), James D. Cox (Author), Waun Ki Hong (Author) Lung cancer is a major cause of cancer-related deaths in men and women. However, since the first edition of Lung Cancer was published 14 years ago, rapid progress in the biology, prevention, diagnosis, and treatment of the disease has been made. |
 |
Lung Cancer: Dana-Farber Cancer Institute Handbook (Dana-Farber Cancer Institute Handbooks) by Arthur T. Skarin MD FACP FCCP (Editor), Paul Lorigan MB FRCP (Editor) Written by highly eminent authors, Lung Cancer - a handbook in the Dana-Farber Cancer Institute series - is produced in full color and is richly illustrated throughout, providing a review of each cancer including its incidence, epidemiology, etiology and histopathology, together with the clinical features. Diagnostic studies and current clinical and pathological staging are also given. Detailed tables are provided with histopathological classification, diagnostic studies and, when important, prognostic factors. Current therapies are also discussed in detail, particularly the management of metastatic lung disease in the context of new and emerging treatments. Comprehensive coverage - from risk and prevention, and screening and diagnosis, through to treatment options (surgery,... |
 |
Lung Cancer: Making Sense of Diagnosis, Treatment, and Options by Lorraine Johnston (Author) Lung cancer is the top cancer killer in the U.S. Yet it receives little attention from the media, and those with lung cancer suffer more blame and stigma than other cancer patients, even though 50 percent of them are former smokers or have never smoked. Lung cancer treatments and the daunting prognosis for some types and stages of lung cancer can significantly impact quality of life. In straightforward language, Lung Cancer: Making Sense of Diagnosis, Treatment & Options addresses its readers' medical, emotional, and support needs. The book includes stories from patients themselves, their families and their healthcare professionals. Author and patient advocate Lorraine Johnston emphasizes using knowledge to dispel fear. The content has been reviewed by top medical experts and physicians... |
 |
100 Questions & Answers About Lung Cancer, Second Edition by Karen Parles (Author), Joan H. Schiller (Author) Empower yourself! No one with lung cancer needs to be alone in their fight against this disease. 100 Questions & Answers About Lung Cancer, Second Edition enables patients and their families to seek our the best treatment possible for early detection of lung cancer. Providing both the doctor s and patient s point of view, this book is a complete guide to understanding treatment options, post-treatment quality of life, sources of support, and much more. Through 100 Questions & Answers About Lung Cancer, Second Edition, expert authors use their experiences with patients to provide support and hope to the tens of thousands of people coping with this disease. |
 |
Mom Lung Cancer Support Kids Dark T-Shirt by CafePress |
 |
A Lung Cancer: Principles and Practice by Harvey I Pass (Editor), David P Carbone (Editor), David H Johnson (Editor), John D Minna (Editor), Andrew T Turrisi (Editor) Thoroughly revised and updated, this Third Edition is the most comprehensive, current reference on lung cancer, with contributions from the world's foremost surgeons, radiation oncologists, medical oncologists, pulmonologists, and basic scientists. This edition includes sixteen new chapters and has been reorganized for greater clinical emphasis. Coverage includes complete information on combined modality treatments for small cell and non-small cell lung cancer and on complications of treatment and management of metastases. Emphasis is also given to early detection, screening, prevention, and new imaging techniques. A new editor, David Carbone, provides state-of-the-art coverage of the molecular genetics and biology of lung cancer. |
| © 2009 BrightSurf.com |